|9 Months Ended|
Sep. 30, 2022
|Share-Based Payment Arrangement [Abstract]|
SCHEDULE OF STOCK OPTION ACTIVITY
At September 30, 2022 and December 31, 2021, the Company had total outstanding options exercisable into shares of the Company’s common stock. These options are fully vested, with exercise prices ranging from $ to $ . Options exercisable into shares expire in December 2027 and the remaining options exercisable into shares expire in April 2028.
The outstanding options had intrinsic value at September 30, 2022.
The entire disclosure for share-based payment arrangement.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef